About
Cancer Treatments targeting extra-chromosomal DNA
Areas of Focus
Categories
DiagnosticsSmall Molecule PharmaceuticalSan Diego & Southern California
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
146
By Phase
PHASE1: 2
By Status
COMPLETED: 1RECRUITING: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06299761Lead Sponsor
Study of the RNR Inhibitor BBI-825 in Subjects With Tumors With Resistance Gene Amplifications
PHASE1Completed
19 participants
Started: Mar 28, 2024 · Completed: Jun 25, 2025
NCT05827614Lead Sponsor
Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications
PHASE1Recruiting
127 participants
Started: Mar 24, 2023 · Completed: Mar 31, 2027
Locations (1)
Headquarters
San Diego, CA, United States
Map
Loading map...